Complete Genomics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 60   

Articles published

GNOM 3.14
price chart
Dako Sponsors European Pathology Congress for Second Straight Year
In addition to Dako Omnis and ClearSeq AML, Agilent will be demonstrating all of its complete pathology and genomics solutions, including NGS, IHC, ISH, histostaining and connectivity. Attendees can visit a fluorescence microscopy room to see some of ...
Young Investors - Why Increasing Risk Is A Bad Idea For Your Portfolio
Those years weren't a complete loss, as I did end up making a few picks that were good enough to break about even overall, but had I known then what I know now I would have approached things much differently.
Bio-Reference Laboratories' (BRLI) CEO Marc Grodman on Q3 2014 Results ...
Good day, ladies and gentlemen, and welcome to the BioReference Laboratories Inc. Third Quarter 2014 Earnings Conference Call.
Update: Myriad Genetics' Patents Are Facing Trouble Again (MYGN)
Sherri Bale, the co-founder and managing director of GeneDx, said, "If we cannot share our data, talk about what we find, and come to conclusions on what things mean, the whole genomics area is going to fall flat on its face. We have to share the data.".
Related articles »  
Art Institute student completes Food Network internship
He held the position of national student director with the Poultry Science Association, and his academic research in the area of poultry nutrition and genomics has been published in peer-reviewed journals including Poultry Science and the Journal of ...
Illumina Partners with AstraZeneca, Sanofi, Janssen in NGS
The collaborations with AstraZeneca PLC (AZN - Analyst Report), Janssen Biotech, Inc., and Sanofi (SNY - Analyst Report) are expected to develop a complete next-generation sequencing (NGS)-based oncology test system which will be a transition from ...
Illumina Partners with AstraZeneca, Sanofi, Janssen in NGS - Analyst Blog  NASDAQ
Related articles »  
Cloud Computing Stocks; Cloud services market is expected to grow to $555 ...
CollabRx, Inc (NasdaqCM:CLRX ) is a recognized leader in cloud-based expert systems to inform health care decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with ...
Related articles »  
Next-Gen Sequencing Is A Numbers Game
Sequencing the human genome the first time cost $3 billion and took 13 years to complete. That was in 2003. Eleven years later ... with a price tag of $10 million. Consisting of 10 ultra-high-throughput sequencers, each capable of generating up to 1.8 ...
Related articles »  
Agios Pharmaceuticals Announces the U.S. FDA Grants Fast Track Designation ...
13, 2014 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced that the U.S.
Related articles »  
Nervana Systems Secures $3.3M in Series A Financing
Nervana Systems logo Nervana Systems, Inc., has announced $3.3M in Series A financing led by DFJ. Steve Jurvetson, DFJ Partner, who currently serves on the boards of Tesla Motors, SpaceX, D-Wave and Synthetic Genomics, will join Nervana's Board of ...
Related articles »